Infection Control Technology
 
HemCon will offer a new proprietary platform technology that offers continuous release hydrogen peroxide functionality and broad spectrum antibacterial and antiseptic properties. The platform technology provides a carefully controlled proprietary process to control dosage and period of delivery. Continuous release over time provides a steady dose while ensuring that the levels produced are below those that could be harmful.
 

The platform will provide a full range of product solutions for the wound care, oral care and personal care markets ranging from antimicrobial professional products to personal hygiene solutions for consumers. Of particular significance, the technology has shown good potential in early studies for the treatment of fungal nail infection. Fungal nail infection affects tens of millions of people in the U.S., and the global market size for its treatment products is approximately US$4 billion.

Learn more: MycosinateTM Treamtent of Onychomycosis.